Elekta (OTCMKTS:EKTAY) Sees Large Volume Increase – Time to Buy?

Elekta AB (OTCMKTS:EKTAY) shares saw unusually-high trading volume on Friday . Approximately 3,601 shares were traded during mid-day trading, an increase of 21% from the previous session’s volume of 2,964 shares.The stock last traded at $6.10 and had previously closed at $6.10.

Elekta Stock Performance

The firm’s 50 day simple moving average is $6.23 and its 200-day simple moving average is $5.41. The company has a market cap of $2.24 billion, a price-to-earnings ratio of 87.01 and a beta of 1.06. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 1.04.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $427.85 million for the quarter, compared to analyst estimates of $436.91 million. Elekta had a net margin of 1.62% and a return on equity of 12.14%. On average, sell-side analysts predict that Elekta AB will post 0.36 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.